Cargando…

Neuroendocrine prostate cancer or prostatitis? An unusual false positive on gallium-68 DOTA-Tyr3-octreotate positron emission tomography/computed tomography in a patient with known metastatic neuroendocrine tumor

The importance of gallium-68 DOTA-Tyr3-octreotate ((68)Ga DOTATATE) positron emission tomography/computed tomography (PET/CT) in the imaging of neuroendocrine tumors (NETs) has grown substantially over the past decade and is becoming markedly more common. We present the case of a male with known met...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Matthew Q, Trenbeath, Zachary, Chin, Bennett B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714147/
https://www.ncbi.nlm.nih.gov/pubmed/31516377
http://dx.doi.org/10.4103/wjnm.WJNM_11_19
_version_ 1783447000387158016
author Schmidt, Matthew Q
Trenbeath, Zachary
Chin, Bennett B
author_facet Schmidt, Matthew Q
Trenbeath, Zachary
Chin, Bennett B
author_sort Schmidt, Matthew Q
collection PubMed
description The importance of gallium-68 DOTA-Tyr3-octreotate ((68)Ga DOTATATE) positron emission tomography/computed tomography (PET/CT) in the imaging of neuroendocrine tumors (NETs) has grown substantially over the past decade and is becoming markedly more common. We present the case of a male with known metastatic NET who underwent (68)Ga DOTATATE PET/CT for restaging, incidentally revealing intense uptake of the prostate with a maximum standard uptake value of 17.4. Due to the patient's medical history, this finding was concerning for neuroendocrine prostate cancer. However, core biopsies of the prostate were negative for malignancy and positive for chronic inflammation. Chronic prostatitis is a very common condition in adult males and is often asymptomatic. Inflammatory conditions, including prostatitis, are important causes of false-positive findings on (68)Ga DOTATATE PET/CT and should be considered as part of the differential diagnosis, even in an asymptomatic patient.
format Online
Article
Text
id pubmed-6714147
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-67141472019-09-12 Neuroendocrine prostate cancer or prostatitis? An unusual false positive on gallium-68 DOTA-Tyr3-octreotate positron emission tomography/computed tomography in a patient with known metastatic neuroendocrine tumor Schmidt, Matthew Q Trenbeath, Zachary Chin, Bennett B World J Nucl Med Case Report The importance of gallium-68 DOTA-Tyr3-octreotate ((68)Ga DOTATATE) positron emission tomography/computed tomography (PET/CT) in the imaging of neuroendocrine tumors (NETs) has grown substantially over the past decade and is becoming markedly more common. We present the case of a male with known metastatic NET who underwent (68)Ga DOTATATE PET/CT for restaging, incidentally revealing intense uptake of the prostate with a maximum standard uptake value of 17.4. Due to the patient's medical history, this finding was concerning for neuroendocrine prostate cancer. However, core biopsies of the prostate were negative for malignancy and positive for chronic inflammation. Chronic prostatitis is a very common condition in adult males and is often asymptomatic. Inflammatory conditions, including prostatitis, are important causes of false-positive findings on (68)Ga DOTATATE PET/CT and should be considered as part of the differential diagnosis, even in an asymptomatic patient. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6714147/ /pubmed/31516377 http://dx.doi.org/10.4103/wjnm.WJNM_11_19 Text en Copyright: © 2019 World Journal of Nuclear Medicine http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Case Report
Schmidt, Matthew Q
Trenbeath, Zachary
Chin, Bennett B
Neuroendocrine prostate cancer or prostatitis? An unusual false positive on gallium-68 DOTA-Tyr3-octreotate positron emission tomography/computed tomography in a patient with known metastatic neuroendocrine tumor
title Neuroendocrine prostate cancer or prostatitis? An unusual false positive on gallium-68 DOTA-Tyr3-octreotate positron emission tomography/computed tomography in a patient with known metastatic neuroendocrine tumor
title_full Neuroendocrine prostate cancer or prostatitis? An unusual false positive on gallium-68 DOTA-Tyr3-octreotate positron emission tomography/computed tomography in a patient with known metastatic neuroendocrine tumor
title_fullStr Neuroendocrine prostate cancer or prostatitis? An unusual false positive on gallium-68 DOTA-Tyr3-octreotate positron emission tomography/computed tomography in a patient with known metastatic neuroendocrine tumor
title_full_unstemmed Neuroendocrine prostate cancer or prostatitis? An unusual false positive on gallium-68 DOTA-Tyr3-octreotate positron emission tomography/computed tomography in a patient with known metastatic neuroendocrine tumor
title_short Neuroendocrine prostate cancer or prostatitis? An unusual false positive on gallium-68 DOTA-Tyr3-octreotate positron emission tomography/computed tomography in a patient with known metastatic neuroendocrine tumor
title_sort neuroendocrine prostate cancer or prostatitis? an unusual false positive on gallium-68 dota-tyr3-octreotate positron emission tomography/computed tomography in a patient with known metastatic neuroendocrine tumor
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714147/
https://www.ncbi.nlm.nih.gov/pubmed/31516377
http://dx.doi.org/10.4103/wjnm.WJNM_11_19
work_keys_str_mv AT schmidtmatthewq neuroendocrineprostatecancerorprostatitisanunusualfalsepositiveongallium68dotatyr3octreotatepositronemissiontomographycomputedtomographyinapatientwithknownmetastaticneuroendocrinetumor
AT trenbeathzachary neuroendocrineprostatecancerorprostatitisanunusualfalsepositiveongallium68dotatyr3octreotatepositronemissiontomographycomputedtomographyinapatientwithknownmetastaticneuroendocrinetumor
AT chinbennettb neuroendocrineprostatecancerorprostatitisanunusualfalsepositiveongallium68dotatyr3octreotatepositronemissiontomographycomputedtomographyinapatientwithknownmetastaticneuroendocrinetumor